Study on the mechanism of demethoxycurcumin inhibiting immune escape in nasopharyngeal carcinoma
Open Access
- 25 March 2026
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- New benzophenone analogs from Nigrospora sphaerica and their inhibitory activity against PD-1/PD-L1 interactionsBioorganic Chemistry, 2024
- Design, synthesis, pharmacological evaluation, and computational study of benzo[d] isothiazol-based small molecule inhibitors targeting PD-1/PD-l1 interactionEuropean Journal of Medicinal Chemistry, 2024
- PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applicationsJournal of Molecular Medicine, 2024
- Immunometabolism unveiled: Pioneering breakthroughs in cancer therapeuticsMolecular Oncology, 2024
- Epidemiology of nasopharyngeal carcinoma: current insights and future outlookCancer and Metastasis Reviews, 2024
- Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escapeBiomedicine & Pharmacotherapy, 2024
- Cancer neoantigens as potential targets for immunotherapyClinical & Experimental Metastasis, 2021
- Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cellsEuropean Journal of Pharmacology, 2021
- Dimethoxycurcumin reduces proliferation and induces apoptosis in renal tumor cells more efficiently than demethoxycurcumin and curcuminChemico-Biological Interactions, 2021
- Chemotherapy and chemo-resistance in nasopharyngeal carcinomaEuropean Journal of Medicinal Chemistry, 2020